These include intracellular shifts of potassium driven by insulin administration (43) (used therapeutically to control hyperglycemia), beta-adrenergic stimulation, and metabolic alkalosis, as well as increased renal losses due to activation of the renin-angiotensin-aldosterone system and nephrotoxic effects of medications or the sepsis itself. This evidence concerns the gene INS and Hyperglycemia.